Press Releases | Potomac Health News

Explore more publications!

Press Releases

Purushothaman Damodara Kumaran, M.D. - 721325 - 12/22/2025

January 13, 2026

Purushothaman Damodara Kumaran, M.D. - 721325 - 12/22/2025

U.S. Food and Drug Administration

Owner: American Government

U.S. Food and Drug Administration

Gov't Institution

Owned By	American Government through Department of Health and Human Services
Year Founded	1906
Website	www.fda.gov
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	United States, Maryland, Silver Springs
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

January 13, 2026

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

GlobeNewswire, Inc.

January 12, 2026

Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer

GlobeNewswire, Inc.

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

January 12, 2026

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

GlobeNewswire, Inc.

January 12, 2026

ARDT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Ardent Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

GlobeNewswire, Inc.

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

January 12, 2026

InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)

GlobeNewswire, Inc.

Gradalis Appoints Steven D. Weinstein as Chief Executive Officer

January 12, 2026

Gradalis Appoints Steven D. Weinstein as Chief Executive Officer

GlobeNewswire, Inc.

Governor Kotek Outlines Next Steps Following Hunger Emergency

January 13, 2026

Governor Kotek Outlines Next Steps Following Hunger Emergency

Oregon Department of Environmental Quality

Owner: American Government

Oregon Department of Environmental Quality

Gov't Institution

Owned By	American Government
Year Founded	1969
Website	www.oregon.gov
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	United States, Oregon, Salem
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Manatt Welcomes Senior Health Care Finance Executive in Washington, D.C.

January 8, 2026

Manatt Welcomes Senior Health Care Finance Executive in Washington, D.C.

GlobeNewswire, Inc.

January 9, 2026

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”

GlobeNewswire, Inc.

Evermore Extends Industry-Leading Retail Partnership with the Addition of United Supermarkets

January 13, 2026

Evermore Extends Industry-Leading Retail Partnership with the Addition of United Supermarkets

GlobeNewswire, Inc.

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

January 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

GlobeNewswire, Inc.

January 9, 2026

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

GlobeNewswire, Inc.

January 9, 2026

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

GlobeNewswire, Inc.

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

January 8, 2026

Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

GlobeNewswire, Inc.

January 8, 2026

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

GlobeNewswire, Inc.

Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology

January 8, 2026

Recludix Pharma Bolsters Scientific Advisory Board with Acclaimed Leaders in the Fields of Rheumatology, Dermatology and JAK/STAT Biology

GlobeNewswire, Inc.

January 8, 2026

Flare Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire, Inc.

January 8, 2026

NervGen Pharma Begins Trading on Nasdaq Today

GlobeNewswire, Inc.

January 8, 2026

Tris Pharma Announces Acceptance of New Publication Highlighting Promise of Dual NOP-MOP (dual-NMR) Agonists for the Treatment of Moderate-to-Severe Pain

GlobeNewswire, Inc.